[DarioHealth in PR Newswire] DarioHealth expands GLP-1 solution with prescribing capabilities through collaboration with MediOrbis, targeting employers and direct-to-consumer markets

NEW YORK, Jan. 14, 2025 /PRNewswire/ — January 14, 2025 — DarioHealth Corp. (Nasdaq: DRIO) (“Dario” or the “Company”), a leader in the global digital health market, today announced a collaboration with MediOrbis, a multi-specialty digital health provider, to add prescribing capabilities to Dario’s GLP-1 behavior change solution for a comprehensive medical weight loss program. This strategic addition creates a fully integrated solution for employers covering weight-loss medications and supports direct-to-consumer offerings, expanding Dario’s addressable market in one of the fastest-growing segments of digital health.

Read more here.